|
1
|
El-Salhy M: Irritable bowel syndrome:
Diagnosis and pathogenesis. World J Gastroenterol. 18:5151–5163.
2012.PubMed/NCBI
|
|
2
|
El-Salhy M: Recent developments in the
pathophysiology of irritable bowel syndrome. World J Gastroenterol.
21:7621–7636. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Salhy M, Hatlebakk JG, Gilja OH and
Hausken T: Irritable bowel syndrome: Recent developments in
diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol
Hepatol. 8:435–443. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Salhy M: Recent advances in the
diagnosis of irritable bowel syndrome. Expert Rev Gastroenterol
Hepatol. 9:1161–1174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Locke GR III, Talley NJ, Fett SL,
Zinsmeister AR and Melton LJ III: Prevalence and clinical spectrum
of gastroesophageal reflux: A population-based study in Olmsted
County, Minnesota. Gastroenterology. 112:1448–1456. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Canavan C, West J and Card T: The
epidemiology of irritable bowel syndrome. Clin Epidemiol. 6:71–80.
2014.PubMed/NCBI
|
|
7
|
Nam SY, Ryu KH and Park BJ: Irritable
bowel syndrome is associated with gastroesophageal reflux symptom
but not erosive esophagitis. J Neurogastroenterol Motil.
19:521–531. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Smart HL, Nicholson DA and Atkinson M:
Gastro-oesophageal reflux in the irritable bowel syndrome. Gut.
27:1127–1131. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee SY, Lee KJ, Kim SJ and Cho SW:
Prevalence and risk factors for overlaps between gastroesophageal
reflux disease, dyspepsia, and irritable bowel syndrome: A
population-based study. Digestion. 79:196–201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jung HK, Halder S, McNally M, Locke GR
III, Schleck CD, Zinsmeister AR and Talley NJ; Overlap of
gastro-oesophageal reflux disease, irritable bowel syndrome, :
Prevalence and risk factors in the general population. Aliment
Pharmacol Ther. 26:453–461. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Talley NJ: Overlapping abdominal symptoms:
Why do GERD and IBS often coexist? Drugs Today (Barc). 42 (Suppl
B):S3–S8. 2006.
|
|
12
|
Lembo A, Zaman M, Jones M and Talley NJ:
Influence of genetics on irritable bowel syndrome,
gastro-oesophageal reflux and dyspepsia: A twin study. Aliment
Pharmacol Ther. 25:1343–1350. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cheung TK, Lam KF, Hu WH, Lam CL, Wong WM,
Hui WM, Lai KC, Lam SK and Wong BC: Positive association between
gastro-oesophageal reflux disease and irritable bowel syndrome in a
Chinese population. Aliment Pharmacol Ther. 25:1099–1104. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu JC, Cheung CM, Wong VW and Sung JJ:
Distinct clinical characteristics between patients with nonerosive
reflux disease and those with reflux esophagitis. Clin
Gastroenterol Hepatol. 5:690–695. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lovell RM and Ford AC: Global prevalence
of and risk factors for irritable bowel syndrome: A meta-analysis.
Clin Gastroenterol Hepatol. 10:712–721 e4. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Noh YW, Jung HK, Kim SE and Jung SA:
Overlap of erosive and non-erosive Reflux diseases with functional
gastrointestinal disorders according to Rome III criteria. J
Neurogastroenterol Motil. 16:148–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lovell RM and Ford AC: Prevalence of
gastro-esophageal reflux-type symptoms in individuals with
irritable bowel syndrome in the community: A meta-analysis. Am J
Gastroenterol. 107:1793–1802. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao Y, Zou D, Wang R, Ma X, Yan X, Man X,
Gao L, Fang J, Yan H, Kang X, et al: Dyspepsia and irritable bowel
syndrome in China: A population-based endoscopy study of prevalence
and impact. Aliment Pharmacol Ther. 32:562–572. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Neumann H, Monkemuller K, Kandulski A and
Malfertheiner P: Dyspepsia and IBS symptoms in patients with NERD,
ERD and Barrett's esophagus. Dig Dis. 26:243–247. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmulson MJ and Drossman DA: What is new
in Rome IV. J Neurogastroenterol Motil. 23:151–163. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Manning AP, Thompson WG, Heaton KW and
Morris AF: Towards positive diagnosis of the irritable bowel. Br
Med J. 2:653–654. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jellema P, van der Windt DA, Schellevis FG
and van der Horst HE: Systematic review: Accuracy of symptom-based
criteria for diagnosis of irritable bowel syndrome in primary care.
Aliment Pharmacol Ther. 30:695–706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ford AC, Talley NJ, Veldhuyzen van Zanten
SJ, Vakil NB, Simel DL and Moayyedi P: Will the history and
physical examination help establish that irritable bowel syndrome
is causing this patient's lower gastrointestinal tract symptoms?
JAMA. 300:1793–1805. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Drossman DA: The functional
gastrointestinal disorders and the Rome II process. Gut. 45 (Suppl
2):II1–II5. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin OS: Colonoscopy in irritable bowel
syndrome: Whom are we reassuring? Gastrointest Endosc. 62:900–902.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Longstreth GF, Thompson WG, Chey WD,
Houghton LA, Mearin F and Spiller RC: Functional bowel disorders.
Gastroenterology. 130:1480–1491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Whitehead WE, Palsson OS and Simrén M:
Irritable bowel syndrome: What do the new Rome IV diagnostic
guidelines mean for patient management? Expert Rev Gastroenterol
Hepatol. 11:281–283. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pardi DS, Smyrk TC, Tremaine WJ and
Sandborn WJ: Microscopic colitis: A review. Am J Gastroenterol.
97:794–802. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sood R, Camilleri M, Gracie DJ, Gold MJ,
To N, Law GR and Ford AC: Enhancing diagnostic performance of
symptom-based criteria for irritable bowel syndrome by additional
history and limited diagnostic evaluation. Am J Gastroenterol.
111:1446–1454. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Armstrong D, Bennett JR, Blum AL, Dent J,
De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE,
Spechler SJ, et al: The endoscopic assessment of esophagitis: A
progress report on observer agreement. Gastroenterology. 111:85–92.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lundell LR, Dent J, Bennett JR, Blum AL,
Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler
SJ, et al: Endoscopic assessment of oesophagitis: Clinical and
functional correlates and further validation of the Los Angeles
classification. Gut. 45:172–180. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takashima T, Iwakiri R, Sakata Y,
Yamaguchi D, Tsuruoka N, Akutagawa K, Komatsu-Tanaka M, Higuchi T,
Tanaka Y, Shimoda R, et al: Endoscopic reflux esophagitis and
Helicobacter pylori infection in young healthy Japanese volunteers.
Digestion. 86:55–58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gyawali CP, Kahrilas PJ, Savarino E,
Zerbib F, Mion F, Smout AJPM, Vaezi M, Sifrim D, Fox MR, Vela MF,
et al: Modern diagnosis of GERD: The Lyon Consensus. Gut.
67:1351–1362. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gwee KA, Lu CL and Ghoshal UC:
Epidemiology of irritable bowel syndrome in Asia: Something old,
something new, something borrowed. J Gastroenterol Hepatol.
24:1601–1607. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hoseini-Asl MK and Amra B: Prevalence of
irritable bowel syndrome in Shahrekord, Iran. Indian J
Gastroenterol. 22:215–216. 2003.PubMed/NCBI
|
|
36
|
Shah SS, Bhatia SJ and Mistry FP:
Epidemiology of dyspepsia in the general population in Mumbai.
Indian J Gastroenterol. 20:103–106. 2001.PubMed/NCBI
|
|
37
|
Ghoshal UC, Abraham P, Bhatt C, Choudhuri
G, Bhatia SJ, Shenoy KT, Banka NH, Bose K, Bohidar NP, Chakravartty
K, et al: Epidemiological and clinical profile of irritable bowel
syndrome in India: Report of the Indian Society of Gastroenterology
Task Force. Indian J Gastroenterol. 27:22–28. 2008.PubMed/NCBI
|
|
38
|
Han SH, Lee OY, Bae SC, Lee SH, Chang YK,
Yang SY, Yoon BC, Choi HS, Hahm JS, Lee MH, et al: Prevalence of
irritable bowel syndrome in Korea: Population-based survey using
the Rome II criteria. J Gastroenterol Hepatol. 21:1687–1692. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kwan AC, Hu WH, Chan YK, Yeung YW, Lai TS
and Yuen H: Prevalence of irritable bowel syndrome in Hong Kong. J
Gastroenterol Hepatol. 17:1180–1186. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Husain N, Chaudhry IB, Jafri F, Niaz SK,
Tomenson B and Creed F: A population-based study of irritable bowel
syndrome in a non-Western population. Neurogastroenterol Motil.
20:1022–1029. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA
and Hu PJ: A population-based epidemiologic study of irritable
bowel syndrome in South China: Stratified randomized study by
cluster sampling. Aliment Pharmacol Ther. 19:1217–1224. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chang FY, Lu CL and Chen TS: The current
prevalence of irritable bowel syndrome in Asia. J
Neurogastroenterol Motil. 16:389–400. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Karaman N, Türkay C and Yönem O: Irritable
bowel syndrome prevalence in city center of Sivas. Turk J
Gastroenterol. 14:128–131. 2003.PubMed/NCBI
|
|
44
|
Celebi S, Acik Y, Deveci SE, Bahcecioglu
IH, Ayar A, Demir A and Durukan P: Epidemiological features of
irritable bowel syndrome in a Turkish urban society. J
Gastroenterol Hepatol. 19:738–743. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Masud MA, Hasan M and Khan AK: Irritable
bowel syndrome in a rural community in Bangladesh: Prevalence,
symptoms pattern, and health care seeking behavior. Am J
Gastroenterol. 96:1547–1552. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Quigley EM, Locke GR, Mueller-Lissner S,
Paulo LG, Tytgat GN, Helfrich I and Schaefer E: Prevalence and
management of abdominal cramping and pain: A multinational survey.
Aliment Pharmacol Ther. 24:411–419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Vandvik PO, Lydersen S and Farup PG:
Prevalence, comorbidity and impact of irritable bowel syndrome in
Norway. Scand J Gastroenterol. 41:650–656. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Drossman DA, Li Z, Andruzzi E, Temple RD,
Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P,
Corazziari E, et al: U.S. householder survey of functional
gastrointestinal disorders. Prevalence, sociodemography, and health
impact. Dig Dis Sci. 38:1569–1580. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Saito YA, Schoenfeld P and Locke GR III:
The epidemiology of irritable bowel syndrome in North America: A
systematic review. Am J Gastroenterol. 97:1910–1915. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Boekema PJ, van Dam van Isselt EF, Bots ML
and Smout AJ: Functional bowel symptoms in a general Dutch
population and associations with common stimulants. Neth J Med.
59:23–30. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Agréus L, Svärdsudd K, Nyrén O and Tibblin
G: Irritable bowel syndrome and dyspepsia in the general
population: Overlap and lack of stability over time.
Gastroenterology. 109:671–680. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hillilä MT and Färkkilä MA: Prevalence of
irritable bowel syndrome according to different diagnostic criteria
in a non-selected adult population. Aliment Pharmacol Ther.
20:339–345. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kay L, Jørgensen T and Jensen KH: The
epidemiology of irritable bowel syndrome in a random population:
Prevalence, incidence, natural history and risk factors. J Intern
Med. 236:23–30. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Thompson WG, Irvine EJ, Pare P, Ferrazzi S
and Rance L: Functional gastrointestinal disorders in Canada: first
population-based survey using Rome II criteria with suggestions for
improving the questionnaire. Dig Dis Sci. 47:225–235. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Boyce PM, Koloski NA and Talley NJ:
Irritable bowel syndrome according to varying diagnostic criteria:
Are the new Rome II criteria unnecessarily restrictive for research
and practice? Am J Gastroenterol. 95:3176–3183. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mearin F, Badia X, Balboa A, Baró E,
Caldwell E, Cucala M, Díaz-Rubio M, Fueyo A, Ponce J and Roset M:
Irritable bowel syndrome prevalence varies enormously depending on
the employed diagnostic criteria: Comparison of Rome II versus
previous criteria in a general population. Scand J Gastroenterol.
36:1155–1161. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
El-Salhy M, Patcharatrakul T, Hatlebakk
JG, Hausken T, Gilja OH and Gonlachanvit S: Chromogranin A cell
density in the large intestine of Asian and European patients with
irritable bowel syndrome. Scand J Gastroenterol. 52:691–697. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
El-Salhy M, Patcharatrakul T, Hatlebakk
JG, Hausken T, Gilja OH and Gonlachanvit S: Enteroendocrine,
Musashi 1 and neurogenin 3 cells in the large intestine of Thai and
Norwegian patients with irritable bowel syndrome. Scand J
Gastroenterol. 52:1331–1339. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Whitehead WE and Drossman DA: Validation
of symptom-based diagnostic criteria for irritable bowel syndrome:
A critical review. Am J Gastroenterol. 105:814–820; quiz 813, 821.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Moayyedi P and Ford AC: Symptom-based
diagnostic criteria for irritable bowel syndrome: The more things
change, the more they stay the same. Gastroenterol Clin North Am.
40:87–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Palsson OS, Whitehead WE, van Tilburg MA,
Chang L, Chey W, Crowell MD, Keefer L, Lembo AJ, Parkman HP, Rao
SS, et al: Rome IV diagnostic questionnaires and tables for
investigators and clinicians. Gastroenterology. Feb 13–2016.(Epub
ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Sood R, Gracie DJ, Gold MJ, To N,
Pinto-Sanchez MI, Bercik P, Moayyedi P, Ford AC and Law GR;
Derivation and validation of a diagnostic test for irritable bowel
syndrome using latent class analysis, : Aliment Pharmacol Ther.
45:824–832. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kruis W, Thieme C, Weinzierl M, Schüssler
P, Holl J and Paulus W: A diagnostic score for the irritable bowel
syndrome. Its value in the exclusion of organic disease.
Gastroenterology. 87:1–7. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Fasano A, Berti I, Gerarduzzi T, Not T,
Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID,
et al: Prevalence of celiac disease in at-risk and not-at-risk
groups in the United States: A large multicenter study. Arch Intern
Med. 163:286–292. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
van der Wouden EJ, Nelis GF and Vecht J:
Screening for coeliac disease in patients fulfilling the Rome II
criteria for irritable bowel syndrome in a secondary care hospital
in The Netherlands: A prospective observational study. Gut.
56:444–445. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Locke GR III, Murray JA, Zinsmeister AR,
Melton LJ III and Talley NJ: Celiac disease serology in irritable
bowel syndrome and dyspepsia: a population-based case-control
study. Mayo Clin Proc. 79:476–482. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hin H, Bird G, Fisher P, Mahy N and Jewell
D: Coeliac disease in primary care: Case finding study. BMJ.
318:164–167. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Shahbazkhani B, Forootan M, Merat S,
Akbari MR, Nasserimoghadam S, Vahedi H and Malekzadeh R: Coeliac
disease presenting with symptoms of irritable bowel syndrome.
Aliment Pharmacol Ther. 18:231–235. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Catassi C, Kryszak D, Louis-Jacques O,
Duerksen DR, Hill I, Crowe SE, Brown AR, Procaccini NJ, Wonderly
BA, Hartley P, et al: Detection of Celiac disease in primary care:
A multicenter case-finding study in North America. Am J
Gastroenterol. 102:1454–1460. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Sanders DS, Carter MJ, Hurlstone DP,
Pearce A, Ward AM, McAlindon ME and Lobo AJ: Association of adult
coeliac disease with irritable bowel syndrome: A case-control study
in patients fulfilling Rome II criteria referred to secondary care.
Lancet. 358:1504–1508. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Korkut E, Bektas M, Oztas E, Kurt M,
Cetinkaya H and Ozden A: The prevalence of celiac disease in
patients fulfilling Rome III criteria for irritable bowel syndrome.
Eur J Intern Med. 21:389–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Sanders DS, Patel D, Stephenson TJ, Ward
AM, McCloskey EV, Hadjivassiliou M and Lobo AJ: A primary care
cross-sectional study of undiagnosed adult coeliac disease. Eur J
Gastroenterol Hepatol. 15:407–413. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
El-Salhy M, Lomholt-Beck B and Gundersen
D: The prevalence of celiac disease in patients with irritable
bowel syndrome. Mol Med Report. 4:403–405. 2011.
|
|
74
|
Aziz I and Sanders DS: The irritable bowel
syndrome-celiac disease connection. Gastrointest Endosc Clin N Am.
22:623–637. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Cash BD, Rubenstein JH, Young PE, Gentry
A, Nojkov B, Lee D, Andrews AH, Dobhan R and Chey WD: The
prevalence of celiac disease among patients with nonconstipated
irritable bowel syndrome is similar to controls. Gastroenterology.
141:1187–1193. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Isgar B, Harman M, Kaye MD and Whorwell
PJ: Symptoms of irritable bowel syndrome in ulcerative colitis in
remission. Gut. 24:190–192. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
El-Salhy M, Gundersen D, Gilja OH,
Hatlebakk JG and Hausken T: Is irritable bowel syndrome an organic
disorder? World J Gastroenterol. 20:384–400. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ansari R, Attari F, Razjouyan H, Etemadi
A, Amjadi H, Merat S and Malekzadeh R: Ulcerative colitis and
irritable bowel syndrome: Relationships with quality of life. Eur J
Gastroenterol Hepatol. 20:46–50. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Simrén M, Axelsson J, Gillberg R,
Abrahamsson H, Svedlund J and Björnsson ES: Quality of life in
inflammatory bowel disease in remission: The impact of IBS-like
symptoms and associated psychological factors. Am J Gastroenterol.
97:389–396. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Keohane J, O'Mahony C, O'Mahony L,
O'Mahony S, Quigley EM and Shanahan F: Irritable bowel
syndrome-type symptoms in patients with inflammatory bowel disease:
A real association or reflection of occult inflammation? Am J
Gastroenterol. 105:1788, 1789–1794; quiz 1795. 2010. View Article : Google Scholar
|
|
81
|
Minderhoud IM, Oldenburg B, Wismeijer JA,
van Berge Henegouwen GP and Smout AJ: IBS-like symptoms in patients
with inflammatory bowel disease in remission; relationships with
quality of life and coping behavior. Dig Dis Sci. 49:469–474. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
El-Salhy M, Halwe J, Lomholt-Beck B and
Gundersen D: The prevalence of inflammatory bowel diseases,
microscopic colitis, and colorectal cancer in patients with
irritable bowel syndrome. Gastroenterol Insights. 3:e32011.
View Article : Google Scholar
|
|
83
|
Tolliver BA, Herrera JL and DiPalma JA:
Evaluation of patients who meet clinical criteria for irritable
bowel syndrome. Am J Gastroenterol. 89:176–178. 1994.PubMed/NCBI
|
|
84
|
Spiller R, Aziz Q, Creed F, Emmanuel A,
Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N, et al:
Guidelines on the irritable bowel syndrome: Mechanisms and
practical management. Gut. 56:1770–1798. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
El-Salhy M, Hatlebakk JG, Gilja OH and
Hausken T: The relation between celiac disease, nonceliac gluten
sensitivity and irritable bowel syndrome. Nutr J. 14:922015.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Heizer WD, Southern S and McGovern S: The
role of diet in symptoms of irritable bowel syndrome in adults: A
narrative review. J Am Diet Assoc. 109:1204–1214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
O'Sullivan MA, Mahmud N, Kelleher DP,
Lovett E and O'Morain CA: Patient knowledge and educational needs
in irritable bowel syndrome. Eur J Gastroenterol Hepatol. 12:39–43.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Stenner PH, Dancey CP and Watts S: The
understanding of their illness amongst people with irritable bowel
syndrome: A Q methodological study. Soc Sci Med. 51:439–452. 2000.
View Article : Google Scholar : PubMed/NCBI
|
